Statistical analysis plan for the Preventing InfusAte injuries Throughout a Childs Hospitalisation (PATCH) trial: a type 1 hybrid randomised controlled trial
In the authors' words
Background: Up to 20% of hospitalised infants with a peripheral intravenous catheter (PIVC) have an infusate-related injury. The PATCH trial is testing whether an IV biosensor (ivWatch) added to standard observation reduces infiltration and extravasation injuries compared with standard observation alone. Methods: PATCH is a multicentre, type 1 hybrid effectiveness-implementation randomised controlled trial at three Queensland hospitals. Infants under 1 year (weighing at least 1000 g) with a PIVC expected to remain more than 24 hours for intermediate- or high-risk infusates, antimicrobials or continuous fluids are randomised 1:1, stratified by site (four strata). The target sample is 532. Analysis: The primary outcome is any infiltration/extravasation injury (mild to severe harm, CCHMC Extravasation Harm Scale), confirmed by a blinded outcome assessment committee. The primary analysis follows intention to treat and uses logistic regression adjusted for randomisation stratum. The risk difference is estimated by standardisation, with the odds ratio also reported. Secondary outcomes include injury severity, time to PIVC failure, dwell time, replacement PIVC, skin injuries and serious adverse events. This plan was finalised on 10/11/2026, during recruitment and before database lock or any unblinded analysis. Trial registration: ACTRN12623000561684.
Appeared: Thursday, November 19. medRxiv. Preprint, not yet peer-reviewed.